LUMAVANCE Trademark

Trademark Overview

On Wednesday, July 18, 2012, a trademark application was filed for LUMAVANCE with the United States Patent and Trademark Office. The USPTO has given the LUMAVANCE trademark a serial number of 79115989. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, July 18, 2022. This trademark is owned by NOVARTIS AG. The LUMAVANCE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines and adjuvants for vaccines
lumavance

General Information

Serial Number79115989
Word MarkLUMAVANCE
Filing DateWednesday, July 18, 2012
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, July 18, 2022
Registration Number4287414
Registration DateTuesday, February 12, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2012

Trademark Statements

Goods and ServicesVaccines and adjuvants for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, February 13, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, February 13, 2023DEATH OF INTERNATIONAL REGISTRATION
Friday, July 17, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, June 16, 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, June 16, 2020INVALIDATION PROCESSED
Wednesday, May 13, 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 13, 2019CANCELLED SECTION 71
Saturday, June 8, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 21, 2013FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 21, 2013FINAL DISPOSITION PROCESSED
Sunday, May 12, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, February 12, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, January 1, 2013NOTIFICATION PROCESSED BY IB
Tuesday, November 27, 2012PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 7, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 7, 2012NOTICE OF PUBLICATION
Tuesday, October 23, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 19, 2012ASSIGNED TO LIE
Friday, October 5, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 5, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 5, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 5, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 23, 2012REFUSAL PROCESSED BY IB
Wednesday, September 5, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 5, 2012REFUSAL PROCESSED BY MPU
Wednesday, September 5, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 4, 2012NON-FINAL ACTION WRITTEN
Saturday, September 1, 2012APPLICATION FILING RECEIPT MAILED
Thursday, August 30, 2012ASSIGNED TO EXAMINER
Tuesday, August 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 27, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

lumavance vaccines adjuvants